文献速递前列腺增生与排尿功能障碍

5α还原酶抑制剂在经尿道前列腺电切术中的作用:随机对照试验的荟萃分析

The role of 5-alpha reductase inhibitors in transurethral resection of the prostate: a meta-analysis of randomised controlled trials.
PubMed 文献 · BJU Int · 2026-01-07

这项荟萃分析纳入30项随机对照试验、共2974例因良性前列腺增生接受经尿道前列腺电切术的患者,评估术前使用5α还原酶抑制剂(5ARI)对围手术期并发症的影响。结果显示,5ARI组术中失血量、术后第1天血红蛋白下降、输血率、手术时间和冲洗液用量均显著低于对照组,切除标本微血管密度和血管内皮生长因子表达也显著降低。结论认为术前使用5ARI可减少术中失血和输血风险,即使短期(2周)治疗也能显著降低前列腺血管性。

要点

  • 术前使用5ARI可显著减少TURP术中失血量(MD -82.58 mL)和输血率(OR 0.31)。
  • 5ARI组手术时间更短(MD -3.47 min)、冲洗液用量更少(MD -2.07 L)。
  • 即使短期(2周)5ARI治疗也能显著降低前列腺血管性。

核心结论

  • 术前使用5ARI可显著减少BPH患者TURP术中失血量和输血风险。
  • 短期(2周)5ARI治疗即可显著降低前列腺血管性。

研究设计与样本

  • 系统检索截至2025年4月的在线数据库,纳入比较术前5ARI与安慰剂/无治疗TURP患者的随机对照试验。
  • 共纳入30项RCT,2974例因BPH行TURP的患者(5ARI组1464例,对照组1410例)。

主要发现

  • 5ARI组术中失血量显著更低(Z=6.37,MD=-82.58 mL,95%CI -107.98至-57.18;P<0.001)。
  • 5ARI组术后第1天血红蛋白下降显著更少(Z=6.84,MD=-0.90 g/dL,95%CI -1.16至-0.64;P<0.001)。
  • 5ARI组切除标本微血管密度显著更低(MD=-6.18 vessels/mm3,P<0.001),VEGF表达显著更少(MD=-3.25,P<0.001)。
  • 5ARI组输血需求显著低于对照组(OR=0.31,P<0.001)。
  • 5ARI组手术时间更短(MD=-3.47 min,P=0.02),冲洗液用量更少(MD=-2.07 L,P<0.001)。

临床怎么用

  • 对于拟行TURP的BPH患者,可考虑术前使用5ARI(非那雄胺或度他雄胺)以减少术中失血和输血风险。
  • 即使术前仅使用2周5ARI,也可能通过降低前列腺血管性而获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To critically evaluate the existing evidence base surrounding the efficacy of preoperative 5-alpha reductase inhibitor (5ARI) administration in the reduction of perioperative complication rates in transurethral resection of prostate (TURP). METHODS: In April 2025, a systematic search of on-line databases was conducted to identify randomised controlled trials (RCTs) that compared surgical outcomes and complication rates in patients undergoing TURP for benign prostatic hyperplasia (BPH) who were treated preoperatively with 5ARI (finasteride or dutasteride) as compared to placebo/none. The efficacy of preoperative finasteride was evaluated through outcomes related to blood loss, rate of blood transfusion, and operative time. The physiological mechanism of 5ARI treatment was evaluated through microvessel density (MVD) and vascular endothelial growth factor (VEGF) expression of the resected specimen. RESULTS: A total of 30 RCTs met the inclusion criteria for this meta-analysis in which a total of 2974 patients underwent TURP for BPH (1464 5ARI: 1410 Control). Intraoperative blood loss was significantly lower among 5ARI-treated patients (Z = 6.37, mean difference [MD] = -82.58 mL, 95% confidence interval [CI] -107.98 to -57.18; P < 0.001), which was reflected in a significantly lesser haemoglobin drop on the first postoperative day (Z = 6.84, MD = -0.90 g/dL, 95% CI-1.16 to -0.64; P < 0.001). The MVD was significantly lower in resected specimens from 5ARI-treated patients (MD = -6.18 vessels/mm3, P < 0.001), whilst expressing significantly less VEGF (MD = -3.25, P < 0.001). Patients treated with 5ARI required blood transfusion less frequently than controls (odds ratio 0.31, P < 0.001). The use of 5ARI was associated with shorter operative time (MD = -3.47 min, P = 0.02) and lower volume of irrigation agents (MD = -2.07 L, P < 0.001). CONCLUSION: Preoperative administration of 5ARIs significantly reduces intraoperative blood loss and risk of requiring blood transfusion in patients undergoing TURP for BPH. Even short durations (2 weeks) of 5ARI therapy can significantly reduce prostate vascularity.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Hehir CM, Calpin GG, Cullivan O, et al. The role of 5-alpha reductase inhibitors in transurethral resection of the prostate: a meta-analysis of randomised controlled trials. BJU Int. 2026. PMID: 41502115. doi:10.1111/bju.70117

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。